Evidence map›Paper›PMID 40314578›Full record

ArticleLab on a chip2025

Understanding the role of vascular stretch on modulation of VWF and ANGPT-2 in continuous flow left ventricular assist device (CF-VAD) patients.

Jay Prakash Sah, Javier E Dominguez De Leon, Ian C Berg, Braden L Cornelius, Daniel B Dekle, Esraa Ismail, Xuanhong Cheng, Guruprasad A Giridharan, Palaniappan Sethu

Abstract read
In one paragraph

Article in Lab on a chip, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jay Prakash SahDivision of Cardiovascular Disease, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA. psethu@uabmc.edu.
Javier E Dominguez De LeonDivision of Cardiovascular Disease, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA. psethu@uabmc.edu.ORCID 0009-0004-4956-3645
Ian C BergDivision of Cardiovascular Disease, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA. psethu@uabmc.edu.
Braden L CorneliusDivision of Cardiovascular Disease, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA. psethu@uabmc.edu.
Daniel B DekleDivision of Cardiovascular Disease, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA. psethu@uabmc.edu.
Esraa IsmailDepartment of Bioengineering, Lehigh University, Bethlehem, Pennsylvania, USA.ORCID 0000-0001-8020-6997
Xuanhong ChengDepartment of Bioengineering and Materials Science and Engineering, Lehigh University, Bethlehem, Pennsylvania, USA.ORCID 0000-0002-6331-8572
Guruprasad A GiridharanDepartment of Bioengineering, J. B. Speed School of Engineering, University of Louisville, Louisville, Kentucky, USA.
Palaniappan SethuDivision of Cardiovascular Disease, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA. psethu@uabmc.edu.ORCID 0000-0002-5794-2037

Funding

Selection of Flow Modulation Protocols for Patients on Continuous Flow Ventricular Assist Devices (CF-VADs)R01HL151663 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SETHU, PALANIAPPAN · 2021 to 2024
$2.3M
National Science Foundation NSF 2004475NHLBI NIH HHS R01 HL151663
6 · The paper itself

Abstract

Non-surgical bleeding is a common complication in patients on continuous flow left ventricular assist device (CF-VAD) support. This study investigates how the transition from cyclic to constant stretch following CF-VAD implantation affects endothelial biosynthesis and release of Von Willebrand factor (VWF) and angiopoietin-2 (ANGPT-2), two molecules that play an essential role in the development of non-surgical bleeding. Human aortic endothelial and umbilical vein endothelial cells (HAECs and HUVECs) were cultured within a uniaxial stretch device that mimics stretch associated with both normal pulsatile and CF-VAD conditions. Following 72 hours of stretch, transcriptional regulation, intracellular accumulation, and secretion of VWF and ANGPT-2 were evaluated using molecular expression profiling and immunofluorescence microscopy. Constant stretch associated with CF-VADs upregulates transcriptional levels of VWF and ANGPT-2 in HAECs and HUVECs compared to physiological cyclic stretch (

Indexed as

Angiopoietin-2Heart-Assist Devicesvon Willebrand FactorCells, CulturedEndothelial CellsHumansHuman Umbilical Vein Endothelial CellsAngiopoietin-2ANGPT2 protein, humanvon Willebrand Factor

Identifiers

PMID40314578
PMCPMC12047207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.